BECN1 and cancer: The BECN1-induced ferroptosis requires AMP-activated protein kinase (AMPK)-mediated phosphorylation of BECN1 at Ser90/93/96 when cancer cells are exposed to system xc− inhibitors, e.g., erastin, sulfasalazine, and sorafenib.